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Icodextrin with nitroprusside increases ultrafiltration and peritoneal
transport during long CAPD dwells. Addition of the nitric oxide (NO)
donor nitroprusside to 1.36% glucose dialysate enlarges the effective
peritoneal surface area during four-hour dwells. The theoretical positive
effect on ultrafiltration is, however, counteracted by an increase in glucose
absorption. The absorption of the glucose polymer icodextrin is much
lower in comparison with glucose-based dialysis solutions, due to its high
molecular weight. In the present study 7.5% icodextrin dialysis solution
with and without the addition of 4.5 mg/liter nitroprusside was studied
during eight-hour CAPD dwells. Two Standard Peritoneal permeability
Analyses, adapted for eight-hour dwells, were performed in 10 stable
CAPD patients. Nitrate and cGMP were measured as parameters of NO
synthesis. The transcapillary ultrafiltration increased in a linear way with
icodextrin (ICO) and was even higher after the addition of nitroprusside
(NP): 666 (ICO) versus 834 (NP) ml/8 hr, P 5 0.03. The effective
lymphatic absorption rate was not different. The resulting net ultrafiltra-
tion increased with nitroprusside: 344 (ICO) versus 540 (NP) ml/8 hr, P ,
0.01. The mass transfer area coefficient of urea increased 15% and that of
creatinine 26% with nitroprusside, consistent with the expected enlarge-
ment of the vascular peritoneal surface area. The increase in protein
clearances was more pronounced the larger the protein: b2-microglobulin
19%, albumin 47%, IgG 63% and a2-macroglobulin 95%. Dialysate/
plasma (D/P) ratios of nitrate were not higher than the expected values on
the basis of its molecular weight (P , 0.001). They increased 19% with
nitroprusside. Also, the D/P ratio cyclic guanosine monophosphate
(cGMP) after four hours increased with nitroprusside (0.39, range 0.13 to
0.55 ICO, and 0.82, range 0.36 to 1.39 NP, P 5 0.01). With nitroprusside
the D/P ratio cGMP was higher than expected after four and eight hours
(P , 0.001). This points to local generation of NO after addition of
nitroprusside. The nitroprusside induced increase in the mass transfer
area coefficients (MTAC) of creatinine and in the ultrafiltration caused an
increase in the creatinine clearance from 4.2 ml/min to 5.0 ml/min during
the eight-hour dwell. This means that nitroprusside adds 3 liters/week to
the peritoneal clearance of creatinine. The adequacy of peritoneal dialysis
can therefore be improved by the addition of nitroprusside to 7.5%
icodextrin, used for the long exchange.
Impaired ultrafiltration in continuous ambulatory peritoneal
dialysis (CAPD) patients is often associated with high transport
rates of low molecular weight solutes [1–4]. This reflects the
presence of a large vascular surface area, which in theory would
allow high water transport rates. However, when a low molecular
weight osmotic agent, such as glucose, is used, this mechanism is
counteracted by a rapid decline of the osmotic gradient, because
of the high absorption rate of glucose [5]. Using a high molecular
weight osmotic agent, like the glucose polymer icodextrin, the
situation is different. Icodextrin has an average molecular weight
of 16,800 Da and the absorption is 16 to 20% during 6- to 12-hour
dwells [6, 7]. This absorption will mainly be by uptake into the
lymphatic system due to its high molecular weight. Therefore,
icodextrin can be expected to increase ultrafiltration in the
presence of a large peritoneal vascular surface area. This has
indeed been found in stable CAPD patients [5, 8] and also during
peritonitis [9].
The nitric oxide donor nitroprusside causes vasodilation, which
is mediated by the synthesis of cyclic guanosine monophosphate
(cGMP) [10]. Nitric oxide has a half-life time of a few seconds and
is oxidized to nitrite and nitrate [11]. Nitrite in the circulation
reacts rapidly with oxyhemoglobin, resulting in a stoichiometric
formation of methemoglobin and nitrate [12]. Exposure of animal
peritoneal tissues to nitroprusside causes opening of previously
not perfused capillaries and enlarges the capillary pore area [13,
14]. Intraperitoneal administration of nitroprusside during four-
hour dwells with 1.36% glucose increased the effective peritoneal
surface area, leading to an increase in the glucose absorption. The
resulting rapid decrease in osmotic gradient counteracted the
initial positive effect on the ultrafiltration by the enlarged surface
area [15]. These results suggested that the addition of nitroprus-
side to icodextrin based dialysis solutions might lead to a marked
increase in ultrafiltration, even during long dwells.
The aim of the present study was to analyze peritoneal fluid and
solute kinetics using a 7.5% icodextrin dialysis solution during an
eight-hour exchange and to investigate the effects of intraperito-
neally administered nitroprusside on these parameters. The con-
tribution of nitric oxide was investigated by analysis of nitrate and
cGMP.
METHODS
Patients
Ten stable CAPD patients were studied twice within one week
with a modified Standard Peritoneal permeability Analysis (SPA),
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during eight-hour dwells [16]. The patients had a mean age of 59
years (range 44 to 68 years). The median body wt was 76.4 kg
(range 66.2 to 86.5 kg) and the median body surface area was 1.95
m2 (range 1.71 to 2.06 m2). They were treated with CAPD for 11
to 48 months, median 20 months. The causes for renal replace-
ment therapy were chronic glomerulonephritis (N 5 3), diabetic
nephropathy (2), hypertensive nephropathy (2), polycystic kidney
disease (1), amyloidosis (1) and analgesic nephropathy (1). All
patients used commercially available glucose dialysate (Dianeal®;
Baxter B.V., Utrecht, The Netherlands) and were free of perito-
nitis at the time of the study and in the four preceding weeks. At
the time of the test two patients used 1.5 liter exchanges and eight
patients used 2.0 liter exchanges of dialysate. The protocol was
approved by the Committee of Medical Ethics of the University
Hospital of Amsterdam, and informed consent was obtained from
all patients after an explanation of the purpose and methods of
the study.
Study design
Two modified SPAs were performed with 7.5% icodextrin
(Icodial®; ML Laboratories PLC, Liverpool, UK), one day with
and the other day without the addition of 4.5 mg/liter sodium
nitroprusside (nitroprusside sodium 1%). The bag was wrapped in
tin foil and nitroprusside was added just before the experiment,
because nitroprusside is not stable in light. The sequence of both
tests was randomized. The SPAs were modified for eight-hour
dwell periods with 7.5% icodextrin. In brief, the peritoneal cavity
was rinsed with 7.5% icodextrin solution before instillation of the
test dialysate into the abdomen. On the nitroprusside day, 4.5
mg/liter nitroprusside was also added to the first rinsing bag.
Dextran 70 (Macrodex®; NPBI, Emmer-Compascuum, The Neth-
erlands; or Hyskon®; Medisan Pharmaceuticals AB, Uppsala,
Sweden) was added to the test solution for measurements of
peritoneal fluid kinetics [17]. Dialysate samples were taken before
inflow and 10, 20, 30, 60, 120, 180, 240, 300, 360, 420 and 480
minutes after inflow of the test solution. These samples were
collected after a temporal drainage of 100 to 200 ml to avoid the
effect of dead space. After drainage of the test solution at 480
minutes, the peritoneal cavity was rinsed with 1.36% glucose.
Samples were taken from this rinsing bag for the calculation of the
residual volume. Blood samples were drawn before and after the
test. Dextran 1 (20 ml, Promiten®; NPBI) was injected intrave-
nously before the test to prevent possible anaphylaxis to dextran
70 [18].
Measurements
Total dextran 70 was determined by means of high-perfor-
mance liquid chromatography as described previously [19], with
the following modifications. Interference of dextrin with the
determination of dextran was suppressed by conversion of dextrin
to oligosaccharides using a-amylase incubation during 60 minutes
at 37°C. This was followed by deproteinization with ZnSO4 and
K4Fe(CN)6. The column used was a Bio-Sil SEC 250 Guard
8037.8 (Biorad). Alpha-amylase is especially able to break the a1
to a4 linkages, resulting in conversion of dextrin to maltose,
maltotriose and other glucose oligomers [20].
Urea, creatinine and urate were determined by enzymatic
methods (Boehringer Mannheim, Mannheim, Germany). Beta-2-
microglobulin was measured with an IMx system using a Micro
particle Enzyme Immunoassay (Abbott Laboratories, North Chi-
cago, IL, USA). Albumin, IgG and a2-macroglobulin were deter-
mined by nephelometry (BN100; Behring, Marburg, Germany).
Blood and dialysate samples for nitrate and cGMP were
centrifuged at 1530 g for ten minutes and immediately stored at
220°C. Nitrate was measured by ion-pair high performance liquid
chromatography. The lower detection limit was 2.5 mmol/liter.
cGMP was measured by an Enzyme Immunoassay (Cayman
Chemical Company, Ann Arbor, MI, USA).
Calculations
The peritoneal fluid parameters were calculated as described
previously [21]. Briefly, fluid transport across the peritoneum
during CAPD is influenced by opposing mechanisms. The trans-
capillary ultrafiltration (TCUF) increases the intraperitoneal vol-
ume; it was calculated as the dilution of the volume marker
dextran 70. The TCUF rate was obtained by dividing the trans-
capillary ultrafiltration by the dwell time. The loss of the volume
marker from the peritoneal cavity was used to calculate the
effective lymphatic absorption rate. This convective loss includes
all pathways of uptake into the lymphatic system, both subdia-
phragmatic and interstitial. The change in intraperitoneal volume
can be obtained by the dilution of the volume marker after
correction for incomplete recovery. The net ultrafiltration rate is
the change in intraperitoneal volume divided by the dwell time
and is equal to the total difference between the TCUF rate and
the lymphatic absorption rate.
The data of the TCUF during the eight-hour dwell were fitted
with linear regression and also with a Lineweaver-Burke plot. A
Lineweaver-Burke plot is the linear regression between the recip-
rocal values of the TCUF and the reciprocal of time [17]. The
correlation coefficients of the individual regression lines were
compared to define which method gave the best fit. Using the
Lineweaver-Burke plot, it is possible to calculate the maximum
theoretical intraperitoneal volume in the absence of lymphatic
flow (TCUFmax) and the transcapillary ultrafiltration in the first
minute (TCUF0-1min) [17].
The transport of low molecular weight solutes was expressed as
mass transfer area coefficients (MTAC). This is the maximum
theoretical clearance of a solute by diffusion at time zero, before
solute transport has started. The MTACs of urea, creatinine and
urate were calculated according to the model of Waniewski,
Werynski, Heimbu¨rger and Lindholm [22], with a correction
factor for plasma water [23]. For nitrate and cGMP, dialysate/
plasma (D/P) ratios were calculated, because in some patients the
cGMP concentrations in dialysate were greater than in plasma
after the addition of nitroprusside. Therefore, it was not possible
to calculate MTACs. The D/P ratios of nitrate and cGMP were
calculated after four and after eight hours, and were corrected for
plasma water by multiplication with 1.05 [24].
Peritoneal clearances of urea, creatinine, b2-microglobulin,
albumin, IgG and a2-macroglobulin were calculated after eight
hours using the equation: Cl (ml/min) 5 (D*V)/(P*t), where Cl is
the clearance, D is the dialysate concentration, V is the dialysate
volume, P is the plasma concentration and t is the dwell time. The
clearances of the four proteins and their free diffusion coefficients
in water were used to calculate the restriction coefficient for
macromolecules. The restriction coefficient (RC) provides a
functional characterization of the intrinsic peritoneal permeability
[21, 25, 26]. This parameter is the slope of the power relationship
between the clearances of the four above-mentioned proteins (Cl)
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and their free diffusion coefficient in water (D20,W) when plotted
on a double logarithmic scale: Cl 5 constant*D20,W
RC.
Based on the power relationship between the D/P ratios of
urea, creatinine, urate and b2-microglobulin, and their molecular
weights, a regression line was calculated. By interpolation of the
molecular weights of nitrate and cGMP on this line, the expected
D/P ratios were calculated, assuming that their dialysate concen-
trations would only be determined by diffusion from the circula-
tion. The differences between observed and expected D/P ratios
of nitrate and cGMP were tested by a modified t-test to analyze
whether the deviation from the regression line was significant.
This test takes the variability of the regression line between
molecular weights and D/P ratios into account [27].
The results are given as median values and ranges, because
most of the data were not normally distributed. Wilcoxon
matched-pairs rank sum tests and Spearman-rank correlation
tests were used for distribution free testing.
RESULTS
Fluid kinetics
The 7.5% icodextrin dialysis solution with and without nitro-
prusside was well tolerated without side effects. The TCUF rate
during the eight-hour dwell was higher after the addition of
nitroprusside: 1.38 ml/min, range 0.86 to 4.49 ml/min (icodextrin)
and 1.75 ml/min, range 1.27 to 4.34 ml/min (icodextrin with
nitroprusside), P 5 0.03. The difference in TCUF was significant
after three hours and at every time point thereafter (Fig. 1). The
effective lymphatic absorption rate with icodextrin was 0.81
ml/min (0.21 to 3.10 ml/min) and did not change with nitroprus-
side: 0.74 ml/min (0.19 to 2.16 ml/min), P 5 0.5. The resulting net
ultrafiltration rate increased 49% during the eight-hour dwell
from 0.72 ml/min, range 20.14 to 1.42 ml/min (icodextrin) to 1.14
ml/min, range 0.48 to 2.50 ml/min (icodextrin with nitroprusside),
P , 0.01. The difference in net ultrafiltration became significant
after two hours (Fig. 1). After eight hours the net ultrafiltration
without nitroprusside was 344 ml (range 265 to 673 ml) and with
nitroprusside 540 ml (225 to 1192 ml), P , 0.01.
Both linear regression and the Lineweaver-Burke plots fitted
well for the TCUF during the dwell. The r-values with icodextrin
were 0.986 (range 0.953 to 0.998) using linear regression and 0.979
(0.924 to 0.990) obtained with Lineweaver-Burke plots, P 5 0.2.
After the addition of nitroprusside the r-values calculated with
linear regression were 0.979 (0.933 to 0.994) and with Lineweaver-
Burke plots were 0.989 (0.953 to 0.999), P 5 0.2.
The TCUFmax increased from 771 ml (381 to 986 ml) with
icodextrin to 1288 ml (635 to 2355 ml) with icodextrin and
nitroprusside, P 5 0.009. The TCUF0-1min was 3.4 ml/min (2.1 to
10.5 ml/min) with icodextrin. After the addition of nitroprusside
the TCUF0-1min was somewhat higher (5.4 ml/min, range 2.0 to
17.9 ml/min), but this difference was not significant (P 5 0.3).
Transport of low molecular weight solutes and proteins
The MTACs of the low molecular weight solutes urea (molec-
ular wt 60 Da), creatinine (molecular wt 113 Da) and urate
(molecular wt 168 Da) increased after the addition of nitroprus-
side (Table 1). The median increase for urea was 15%, for
creatinine 26% and for urate 40%. The clearances of urea and
creatinine are shown in Table 2. The addition of nitroprusside
caused a 13% increase in the clearance of urea and a 19%
Table 1. Mass transfer area coefficients (MTACs) of the low molecular
weight solutes, peritoneal protein clearances and the restriction
coefficients for macromolecules
7.5% Icodextrin 1 Nitroprusside P value
MTAC ml/min
Urea 12.1 (7.6–20.0) 15.9 (9.6–21.3) 0.1
Creatinine 7.9 (5.0–16.1) 10.5 (7.3–17.5) 0.006
Urate 6.5 (4.2–15.2) 8.9 (5.8–21.5) 0.006
Clearance ml/min
b2-microglobulin 983 (598–2514) 1177 (863–2877) 0.07
Albumin 84 (51–169) 125 (78–258) 0.008
IgG 57 (27–100) 90 (48–182) 0.01
a2-macroglobulin 19 (8–63) 37 (17–88) 0.02
Restriction
coefficient
2.36 (1.75–2.49) 2.06 (1.66–2.33) 0.01
Values are given as medians with ranges.
Fig. 1. The time course of the transcapillary ultrafiltration (f), lymphatic absorption () and the resulting change in intraperitoneal volume () with
7.5% icodextrin dialysate (A) and after the addition of nitroprusside (B). *P # 0.05 and **P # 0.01 when compared to the icodextrin experiment without
nitroprusside.
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increase in the clearance of creatinine during the eight-hour
dwell. Also, the protein clearances were higher with nitroprusside.
This nitroprusside induced increase of clearances was more
pronounced the larger the protein: 19% for b2-microglobulin
(molecular wt 11,800 Da), 47% for albumin (molecular wt 69,000
Da), 63% for IgG (molecular wt 150,000 Da) and 95% for
a2-macroglobulin (molecular wt 820,000 Da). The albumin loss
during this period increased 0.92 grams with nitroprusside (P 5
0.02). The restriction coefficient calculated on the four proteins
decreased from 2.36 (1.75 to 2.49) to 2.06 (1.66 to 2.33) with
nitroprusside (P 5 0.01).
A positive correlation was found between the restriction coef-
ficient for macromolecules and the time treated with CAPD (r 5
0.7, P 5 0.04), using icodextrin. This correlation disappeared after
the addition of nitroprusside (r 5 20.1, P 5 0.70). Figure 2 shows
the restriction coefficient for macromolecules with icodextrin and
after the addition of nitroprusside for each patient. The effect of
nitroprusside on the restriction coefficient was greater for long-
term CAPD patients. This resulted in a positive correlation
between the time treated with CAPD and the relative decrease in
the restriction coefficients for macromolecules by nitroprusside
(r 5 0.8, P 5 0.01). Also, a positive correlation was found between
the CAPD treatment time and the relative increase in albumin
loss during the eight-hour dwell with icodextrin and nitroprusside
(r 5 0.7, P 5 0.03).
The nitroprusside induced increase in the MTAC of creatinine,
an indication for an increase in the vascular surface area, was
accompanied by an increase in intraperitoneal volume, as shown
in Figure 3 for each individual patient.
Parameters of nitric oxide
The D/P ratio of nitrate was higher with nitroprusside both
after four hours and after eight hours: after four hours 0.73, range
0.54 to 0.90 (icodextrin) and 0.83, range 0.72 to 0.88 (icodextrin
with nitroprusside), P 5 0.04. The D/P ratio of nitrate after eight
hours was 0.82, range 0.76 to 1.06 (icodextrin) and 0.87, range 0.83
to 1.19 (icodextrin with nitroprusside), P 5 0.01. Regardless of the
addition of nitroprusside, the observed D/P ratios of nitrate were
not higher than the expected values based on its molecular weight,
both after four and after eight hours (Fig. 4).
The D/P ratio of cGMP was 0.39 (0.13 to 0.55) after four hours
and 0.62 (0.26 to 0.74) after eight hours, during the icodextrin
dwell. These D/P ratios of cGMP were not greater than expected
on the basis of its molecular weight (Fig. 4). After the addition of
nitroprusside the D/P ratio of cGMP increased to 0.82 (0.36 to
1.39) after four hours (P 5 0.01) and 0.76 (0.32 to 1.13) after eight
hours (P 5 0.08). This increase in the D/P ratio was greater than
expected: P , 0.001, both after four and after eight hours (Fig. 4).
After four hours the D/P ratio of cGMP even exceeded 1.0 in four
patients and after eight hours this occurred in two patients.
During the icodextrin dwell the D/P ratio of cGMP was greater
after eight hours in comparison with values after four hours (P 5
0.01). With nitroprusside the D/P ratio of cGMP was greater after
four hours (P 5 0.05) compared to values after eight hours.
DISCUSSION
The kinetics of fluid and solute transport with 7.5% icodextrin
based dialysate during eight-hour exchanges were in accordance
with expectations based on four-hour exchanges. The addition of
Table 2. Peritoneal clearances of urea and creatinine and the albumin
loss during 8-hour dwells
7.5% Icodextrin 1 Nitroprusside P value
Clearance ml/min
Urea 4.8 (3.2–6.5) 5.4 (3.7–7.1) 0.008
Creatinine 4.2 (2.8–6.3) 5.0 (3.3–7.0) 0.006
Albumin loss g/8 hr 1.48 (0.89–2.69) 2.40 (1.25–2.76) 0.02
Values are given as medians with ranges.
Fig. 2. The restriction coefficient for macromolecules without (2) and
with () nitroprusside in relation to the time treated with CAPD. Each
individual patient is represented by an arrow. The length of the arrow
indicates the magnitude of the effect of nitroprusside on the restriction
coefficient. The regression lines are based upon the relationship between
the time treated with CAPD and the restriction coefficient with icodextrin
(r 5 0.7, P 5 0.04) and the CAPD treatment time and the restriction
coefficient with icodextrin and nitroprusside (r 5 20.1, P 5 0.70).
Fig. 3. The relationship between the MTAC of creatinine and the in-
crease in intraperitoneal volume by icodextrin after eight hours. The 
shows the same relationship after the addition of nitroprusside. Arrows
are drawn from the value without nitroprusside to the value after the
addition of nitroprusside for each individual patient.
Douma et al: Icodextrin and nitroprusside in CAPD 1017
nitroprusside lead to marked increments in the transport of fluids
and solutes. These findings will be discussed according to physi-
ological mechanisms and to potential clinical relevance.
Fluid transport
Icodextrin 7.5% is a solution hypotonic to uremic plasma. It
induces ultrafiltration across the capillary wall by colloid osmosis.
This process is based upon the principle that fluid flow across a
membrane permeable to small solutes, occurs in the direction of
relative excess of impermeable large solutes, rather than along the
osmolality gradient. The TCUF induced by the 7.5% icodextrin-
based dialysis solution increased in a linear way during an
eight-hour dwell. When 4.5 mg/liter nitroprusside was added to
the icodextrin based dialysate, the ultrafiltration could be aug-
mented by almost 50%. These observations extend the findings
that the ultrafiltration increases linearly during a four-hour ex-
change [8]. Furthermore, they support the clinical data showing
that icodextrin is especially effective during long exchanges and in
situations with impaired ultrafiltration on glucose based solutions
due to a large vascular surface area [6, 7]. The effects of a
nitroprusside induced increase in the peritoneal vascular surface
area on the TCUF are in accordance with previous studies.
Patients with a large effective peritoneal surface area, due to
ultrafiltration failure or peritonitis, showed the largest benefit by
using a glucose polymer solution in stead of glucose based
dialysate [5, 9]. The relationship found previously between the
MTAC of creatinine, as a marker of the effective peritoneal
surface area, and the TCUF rate during icodextrin [8] could be
confirmed in the present study (without nitroprusside r 5 0.6 and
P 5 0.07; with nitroprusside r 5 0.7 and P 5 0.03). Increasing the
vascular surface area with nitroprusside increased the ultrafiltra-
tion rate even more. During dwells with glucose dialysate the
positive effect of nitroprusside on ultrafiltration is only present
during the initial phase of a dwell, because it is counteracted by
the increased absorption of glucose by diffusion [15]. As icodex-
trin disappears from the peritoneal cavity by uptake into the
lymphatic system, diffusion can probably be neglected. None of
the patients included in the present study had ultrafiltration
failure. The presence of a large vascular surface area is the most
frequent cause of impaired ultrafiltration [28]. It cannot be
predicted from our results whether the addition of nitroprusside
to icodextrin would increase their vascular surface area even more
with a subsequent increase in ultrafiltration.
The best fit for the TCUF during a glucose dwell is the
Lineweaver-Burke plot [17]. Linear regression was found to fit
best for four-hour dwells with icodextrin [8]. In the present study,
Fig. 4. Regression lines based upon the relationship between the median D/P ratios of urea, creatinine, urate and b2-microglobulin and their
molecular weights (v). The positions of nitrate and cGMP (V) are given in relation to their molecular weight during various conditions. (A) Icodextrin
at 240 minutes. (B) Icodextrin with nitroprusside at 240 minutes. (C) Icodextrin at 480 minutes. (D) Icodextrin with nitroprusside at 480 minutes. *P ,
0.001 for increase in the observed D/P ratio cGMP with regard to the expected D/P ratio cGMP.
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both linear regression and the Lineweaver-Burke plot fitted well
for the TCUF during eight-hour icodextrin exchanges. Neither fit
was significantly better, but it was evident that the TCUF in-
creased during the whole dwell. The TCUFmax reported for 1.36%
glucose dwells averaged 641 ml [17]. The present study shows a
20% higher TCUFmax with icodextrin and a 101% increase with
icodextrin and nitroprusside.
The TCUF0-1min was not significantly higher after the addition
of nitroprusside, probably because the icodextrin dialysate is
hypotonic compared to uremic plasma. Consequently, the initial
crystalloid osmotic pressure gradient causes ultrafiltration from
the dialysate to the circulation during the first part of the dwell.
This will be even more pronounced after the nitroprusside
induced increase of the vascular peritoneal surface area.
Transport of low molecular weight solutes
The absolute values of MTACs of low molecular weight solutes
were somewhat lower than previously reported for glucose- and
icodextrin based dialysate during four-hour dwells [8, 15, 29]. This
is most likely due to the eight-hour duration of the dwells in the
present study. The nitroprusside induced increase in the MTACs
was, however, similar during four and eight-hour dwells and
averaged 15 to 40% [15]. The combination of higher MTACs and
higher ultrafiltration rates resulted in a median increase in the
peritoneal creatinine clearance of 15% or 0.8 ml/min during the
eight-hour dwell with icodextrin and nitroprusside. It can be
calculated from our data (median creatinine clearance 4.2 ml/
min) that the daily use of an eight-hour overnight dwell with
icodextrin during seven days a week will add 14 liters per week
(4.2 3 60 3 8 3 7) to the total creatinine clearance obtained by
the exchanges during daytime. For comparison, the contribution
of the night dwell to total creatinine clearance in a patient with
ultrafiltration failure, who drains only 1800 ml of a 2 liter glucose
solution, averages only 11 liters per week. The routine addition of
nitroprusside to icodextrin for one long dwell everyday would
further increase the total creatinine clearance by 3 liters to 17
liters per week, compared to the total clearance obtained with
daytime ambulatory peritoneal dialysis. This may be of signifi-
cance in clinical practice, because the CANUSA study has shown
that an increment of the creatinine clearance of 5 liter/week/1.73
m2 reduced the relative mortality risk by 7% [30]. Although it
cannot be concluded from these observational data that increasing
peritoneal creatinine clearance will prolong the survival of peri-
toneal dialysis patients, the increase of 6 liters per week in
creatinine clearance makes it more feasible to meet the recently
formulated adequacy targets [31].
Transport of serum proteins
The median values for the peritoneal clearances of individual
serum proteins and the peritoneal restriction coefficient calcu-
lated on these proteins was similar to previously published values.
In accordance with earlier published cross-sectional and longitu-
dinal data by our group [32, 33], the restriction coefficient was
higher in long-term CAPD patients. As the restriction coefficient
can be considered a reflection of the large pore radius, these
observations suggest a smaller radius of these pores in long-term
CAPD. However, the relationship with time disappeared after the
addition of nitroprusside. This suggests that the dilating capacity
of these pores is unaffected by the duration of CAPD. Park et al
[34] compared new CAPD patients to long-term CAPD patients
and found that the nitroprusside induced increase in drained
protein concentration was more pronounced in the new CAPD
patients. This is in contrast with the results of our present study
where a positive correlation was found between the CAPD
treatment time and the proportional increase in albumin loss
during eight-hour dwells. The difference of our results with that of
Park et al might be that short exchanges were used in the latter
study. It should also be realized that the number of patients is
small and interpretation of the relationship between protein
kinetics and time on CAPD is speculative, as the anatomic
equivalent of these large pores has not been established with
certainty [35]. When one assumes that venular interendothelial
gaps, that can be provoked by local administration of vasodilators
such as histamine, represent the large pore system [36] the
following hypothesis can be raised. Mesothelial cells synthesize
many vasoactive substances such as prostaglandin E2 and prosta-
cyclin [37]. Long-term peritoneal dialysis can lead to a reduction
of mesothelial cell mass. This may lead to a lower basal vasodi-
lating tone in the peritoneal microvasculature and therefore
higher restriction coefficients. The addition of nitroprusside
causes so much vasodilation that the effect of the basal vasodilat-
ing tone is overruled.
The effect of nitroprusside administration on peritoneal albu-
min clearance led to an increased albumin loss in peritoneal
effluent. The median increase was, however, only 0.92 grams per
eight-hour exchange. This would increase peritoneal albumin loss
from 3 to 4 grams per 24 hours to 4 to 5 grams per 24 hours [38].
This is unlikely to influence the serum albumin concentration
especially as Kaysen and Schoenfeld found that albumin synthesis
in CAPD patients increased with increased albumin loss [39].
Moreover, various studies have shown that the main determinants
of serum albumin concentration in CAPD patients were age and
the presence of a systemic disease such as diabetes mellitus, and
not peritoneal albumin loss [40, 41]. It can be expected that the
favorable effects of nitroprusside on ultrafiltration and small
solute clearances outweigh the limited increase in peritoneal
protein loss.
Parameters of nitric oxide
The D/P ratios of nitrate increased with nitroprusside, due to
the larger effective peritoneal surface area. Nitrate, formed from
the degradation of nitric oxide in the circulation, will diffuse from
the circulation to the dialysate. Therefore, the D/P ratio increases
during the dwell. The D/P ratio of nitrate during the administra-
tion of nitroprusside could totally be explained by transperitoneal
transport. This implies that there was no detectable local produc-
tion of nitrate in the peritoneal cavity. It suggests that nitric oxide,
released from nitroprusside, diffuses from the peritoneal cavity to
the circulation, where the oxidation to nitrate takes place. In a
previous study the D/P ratios of cGMP were higher than expected
on the basis of its molecular weight after the addition of nitro-
prusside [15]. We concluded that this could be explained by local
generation of cGMP, induced by nitric oxide. This has been
confirmed in the present study. Both after four and after eight
hours the D/P ratios of cGMP were above the transport line. D/P
ratios exceeding 1.0 with nitroprusside is a second reason for local
generation of cGMP. The third indication is the higher D/P ratio
of cGMP after four hours in comparison with eight hours. It is
likely that the locally generated cGMP diffused from the dialysate
to the circulation.
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It can be concluded that the addition of nitroprusside enlarged
the vascular surface area, leading to an increase in the MTACs of
low molecular weight solutes and in the clearances of urea,
creatinine and proteins. Furthermore, this increase in effective
peritoneal surface area enhanced the icodextrin induced ultrafil-
tration during eight-hour dwells. The adequacy of peritoneal
dialysis in CAPD patients can therefore be improved by the
addition of nitroprusside to a 7.5% icodextrin dialysis solution.
The benefit will especially be during long exchanges, like the night
dwell for CAPD patients and the exchange during the day for
automated peritoneal dialysis patients.
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APPENDIX
Abbreviations used in this article are: CAPD, continuous ambulatory
peritoneal dialysis; cGMP, cyclic guanosine monophosphate; D/P ratio,
dialysate/plasma ratio; ICO, icodextrin; MTAC, mass transfer area coef-
ficient; NO, nitric oxide; NP, nitroprusside; RC, restriction coefficient;
SPA, Standard Peritoneal permeability Analysis; TCUF, transcapillary
ultrafiltration.
REFERENCES
1. WIDERO¨E TE, SMEBY LC, MJÅLAND S, DAHL K, BERG KJ, WESSEL
AAS T: Long-term changes in transperitoneal water transport during
continuous ambulatory peritoneal dialysis. Nephron 38:238–247, 1984
2. KREDIET RT, BOESCHOTEN EW, ZUYDERHOUDT FMJ, ARISZ L:
Peritoneal transport characteristics of water, low-molecular weight
solutes and proteins during long-term continuous ambulatory perito-
neal dialysis. Perit Dial Bull 6:61–65, 1986
3. VERGER C, LARPENT L, CELICOUT B: Clinical significance of ultrafil-
tration failure on CAPD, in Peritoneal Dialysis, edited by LA GRECA G,
CHIARAMONTE S, FABRIS A, FECIANI M, RONCO C, Milan, Wichtig
Editore, 1986, pp 91–94
4. HEIMBU¨RGER O, WANIEWSKI J, WERYNSKI A, TRANAEUS A, LINDHOLM
B: Peritoneal transport in CAPD patients with permanent loss of
ultrafiltration capacity. Kidney Int 38:495–506, 1990
5. IMHOLZ ALT, BROWN CB, KOOMEN GCM, ARISZ L, KREDIET RT: The
effect of glucose polymers on water removal and protein clearances
during CAPD. Adv Perit Dial 9:25–30, 1993
6. MISTRY CD, MALLICK NP, GOKAL R: The advantage of glucose
polymer as an osmotic agent in continuous peritoneal dialysis. Proc
EDTA-ERA 22:415–420, 1985
7. MISTRY CD, GOKAL R, PEERS E, MIDAS STUDY GROUP: A random-
ized multicenter trial comparing isosmolar icodextrin with hyperos-
molar glucose solutions in CAPD. Kidney Int 46:496–503, 1994
8. HO-DAC-PANNEKEET MM, SCHOUTEN N, LANGEDIJK MJ, HIRALALL
JK, DE WAART DR, STRUIJK DG, KREDIET RT: Peritoneal transport
characteristics with glucose polymer based dialysate. Kidney Int 50:
979–986, 1996
9. GOKAL R, MISTRY CD, PEERS E, MIDAS STUDY GROUP: Peritonitis
occurrence in a multicenter study of icodextrin and glucose in CAPD.
Perit Dial Int 15:226–230, 1995
10. GRUETTER CA, GRUETTER DY, LYON JE, KADOWITZ PJ, IGNARRO LJ:
Relationship between cyclic guanosine 3,5-monophosphate formation
and relaxation of coronary arterial smooth muscle by glyceryl trini-
trate, nitroprusside, nitrate and nitrate oxide: Effects of methylene
blue and methemoglobin. J Pharmacol Exp Ther 219:181–186, 1981
11. KELM M, SCHRADER J: Control of coronary vascular tone by nitric
oxide. Circ Res 66:1561–1575, 1990
12. KOSAKA H, IMAIZUMI K, IMAI K, TYUMA I: Stoichiometry of the
reaction of oxyhemoglobin with nitrite. Biochim Biophys Acta 5811:
184–188, 1979
13. NOLPH KD, GHODS AJ, BROWN PA, MILLER FN, HARRIS P, PYLE K,
POPOVICH R: Effects of nitroprusside on peritoneal mass transfer
coefficients and microvascular physiology. ASAIO Trans 23:210–218,
1977
14. MILLER FN, JOSHUA IG, HARRIS PD, WIEGMAN DL, JAUCHEM JR:
Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol
17:51–58, 1979
15. DOUMA CE, DE WAART DR, STRUIJK DG, KREDIET RT: The nitric
oxide donor nitroprusside intraperitoneally affects peritoneal perme-
ability in CAPD. Kidney Int 51:1885–1892, 1997
16. PANNEKEET MM, IMHOLZ ALT, STRUIJK DG, KOOMEN GCM, LANGE-
DIJK MJ, SCHOUTEN N, DE WAART DR, HIRALALL JK, KREDIET RT:
The standard peritoneal permeability analysis: A tool for the assess-
ment of peritoneal permeability characteristics in CAPD patients.
Kidney Int 48:866–875, 1995
17. KREDIET RT, STRUIJK DG, KOOMEN GCM, ARISZ L: Peritoneal fluid
kinetics during CAPD measured with intraperitoneal dextran 70.
ASAIO Trans 37:662–667, 1991
18. RENCK H, LJUNGSTRO¨M HG, HEDIN H, RICHTER W: Prevention of
dextran induced anaphylactic reaction by hapteen inhibition. Acta
Chir Scan 149:355–360, 1983
19. KOOMEN GCM, KREDIET RT, LEEGWATER ACJ, STRUIJK DG, ARISZ
L, HOEK FJ: A fast reliable method for the measurement of intraperi-
toneal dextran 70, used to calculate lymphatic absorption. Adv Perit
Dial 7:10–14, 1991
20. STEGEMAN G, DE WAART DR, HIRALALL JK, KREDIET RT, ARISZ L,
HOEK FJ: Measurement of dextran 70 in peritoneal dialysate contain-
ing icodextrin. (abstract) Perit Dial Int 15(Suppl 2):S18, 1995
21. IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L, KREDIET RT:
Effect of dialysate osmolarity on the transport of low-molecular
weight solutes and proteins during CAPD. Kidney Int 43:1339–1346,
1993
22. WANIEWSKI J, WERYNSKI A, HEIMBU¨RGER O, LINDHOLM B: Simple
models for description of small-solute transport in peritoneal dialysis.
Blood Purif 9:129–141, 1991
23. WANIEWSKI J, HEIMBU¨RGER O, WERYNSKI A, LINDHOLM B: Aqueous
solute concentrations and evaluation of mass transport coefficients in
peritoneal dialysis. Nephrol Dial Transplant 7:50–56, 1992
24. HART O: Water balance; transport of fluids and solutes, in Human
Physiology, edited by SCHMIDT RF, THEWS G, Berlin, Springer-Verlag,
1983, pp 653–654
25. ZEMEL D, KREDIET RT, KOOMEN GCM, STRUIJK DG, ARISZ L:
Day-to-day variability of protein transport used as a method for
analyzing peritoneal permeability in CAPD. Perit Dial Int 11:217–233,
1991
26. KREDIET RT, ZEMEL D, IMHOLZ ALT, STRUIJK DG: Impact of surface
area and permeability on solute clearances. Perit Dial Int 14(Suppl
3):S70–S77, 1994
27. REDDINGIUS RE, SCHRO¨DER CH, DAHA MR, WILLEMS JL, KOSTER
AM, MONNENS LAH: Complement in serum and dialysate in children
on continuous ambulatory peritoneal dialysis. Perit Dial Int 15:49–53,
1995
28. HO-DAC-PANNEKEET MM, ATASEVER B, STRUIJK DG, KREDIET RT:
Analysis of ultrafiltration failure in peritoneal dialysis patients by
means of standard peritoneal permeability analysis. Perit Dial Int
17:144–150, 1997
29. DOUMA CE, DE WAART DR, STRUIJK DG, KREDIET RT: Effect of
amino acid based dialysate on peritoneal blood flow and permeability
in stable CAPD patients: A potential role for nitric oxide? Clin
Nephrol 45:295–302, 1996
30. CANADA-USA (CANUSA) PERITONEAL DIALYSIS STUDY GROUP:
Adequacy of dialysis and nutrition in continuous peritoneal dialysis:
Association with clinical outcomes. J Am Soc Nephrol 7:198–207, 1996
31. BLAKE P, BURKART JM, CHURCHILL DN, DAUGIRDAS J, DEPNER T,
HAMBURGER RJ, HULL AR, KORBET SM, MORAN J, NOLPH KD,
OREOPOULOS DG, SCHREIBNER M, SODERBLOOM R: Recommended
clinical practices for maximizing peritoneal dialysis clearances. Perit
Dial Int 16:448–456, 1996
Douma et al: Icodextrin and nitroprusside in CAPD1020
32. STRUIJK DG, KREDIET RT, KOOMEN GCM, HOEK FJ, BOESCHOTEN
EW, VAN DER REIJDEN HJ, ARISZ L: Functional characteristics of the
peritoneal membrane in long-term continuous ambulatory peritoneal
dialysis. Nephron 59:213–220, 1991
33. HO-DAC-PANNEKEET MM, KOOPMANS JG, STRUIJK DG, KREDIET RT:
Restriction coefficients of low molecular weight solutes and macro-
molecules during peritoneal dialysis. Adv Perit Dial 13:17–22, 1997
34. PARK MS, LEE J, LEE MS, BAICK SH, HWANG SD, LEE HB: Peritoneal
solute clearances after four years of continuous ambulatory peritoneal
dialysis (CAPD). Perit Dial Int 9:75–78, 1989
35. FOX J, GALEY F, WAYLAND H: Action of histamine on the mesenteric
microvasculature. Microvasc Res 19:108–126, 1980
36. MILLER FN, JOSHUA IG, ANDERSON GL: Quantitation of vasodilator-
induced macromolecular leakage by in vivo fluorescent microscopy.
Microvasc Res 24:56–67, 1982
37. STYLIANOU E, JENNER LA, DAVIES M, COLES GA, WILLIAMS JD:
Isolation, culture and characterization of human peritoneal mesothe-
lial cells. Kidney Int 37:1563–1570, 1990
38. KREDIET RT, ZUYDERHOUDT FMJ, BOESCHOTEN EW, ARISZ L:
Peritoneal permeability to proteins in diabetic and non-diabetic
continuous ambulatory peritoneal dialysis patients. Nephron 42:133–
140, 1986
39. KAYSEN GA, SCHOENFELD PY: Albumin homeostasis in patients
undergoing continuous ambulatory peritoneal dialysis. Kidney Int
25:107–114, 1984
40. BLAKE PG, FLOWERDEW G, BLAKE RM, OREOPOULOS DG: Serum
albumin in patients on continuous ambulatory peritoneal dialysis—
Predictors and correlations with outcomes. J Am Soc Nephrol 3:1501–
1507, 1993
41. STRUIJK DG, KREDIET RT, KOOMEN GCM, BOESCHOTEN EW, ARISZ
L: The effect of serum albumin at the start of continuous ambulatory
peritoneal dialysis treatment on patient survival. Perit Dial Int 14:121–
126, 1994
Douma et al: Icodextrin and nitroprusside in CAPD 1021
